Get to know about the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, designed to assess the effects on major vascular outcomes of lowering the glycated hemoglobin value in patients with type 2 diabetes.
